4803011000001101: Herceptin 150mg powder for solution for injection vials (Roche Products Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\UK product\Virtual medicinal product\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\UK product\Virtual therapeutic moiety\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\UK product\Virtual therapeutic moiety\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\UK product\Trade family\Herceptin\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Trastuzumab\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing trastuzumab\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)
\Medicinal product\Product manufactured as parenteral dose form\Product containing trastuzumab in parenteral dose form (medicinal product form)\Product containing only trastuzumab in parenteral dose form (medicinal product form)\Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection\Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

18444701000001117 Herceptin 150mg powder for solution for injection vials (Roche Products Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

106596701000001113 Herceptin 150mg powder for concentrate for solution for infusion vials (Roche Products Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	VMP prescribing status (attribute)	Caution - AMP level prescribing advised	true	Inferred relationship	Existential restriction modifier
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	Is a	Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	Has excipient	Polysorbate	false	Inferred relationship	Existential restriction modifier
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	Has active ingredient	Trastuzumab	false	Inferred relationship	Existential restriction modifier
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	false	Inferred relationship	Existential restriction modifier
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	Has manufactured dose form	Powder for conventional release solution for injection	false	Inferred relationship	Existential restriction modifier
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	Is a	Herceptin	true	Inferred relationship	Existential restriction modifier
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	Has specific active ingredient	Trastuzumab	true	Inferred relationship	Existential restriction modifier
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	Has dispensed dose form	Powder for infusion solution	false	Inferred relationship	Existential restriction modifier
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	Has manufactured dose form	Injection	false	Inferred relationship	Existential restriction modifier
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	Has dispensed dose form	Powder for conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd) 1 vial	Is pack of	False	Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	Inferred relationship	Existential restriction modifier
Herceptin 150mg powder for solution for injection vials (Roche Products Ltd) 1 vial	Has AMP	True	Herceptin 150mg powder for solution for injection vials (Roche Products Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
18444701000001117	Herceptin 150mg powder for solution for injection vials (Roche Products Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
106596701000001113	Herceptin 150mg powder for concentrate for solution for infusion vials (Roche Products Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module